Ro Khanna sold NEURIG DR PEPPER (INCOMN) (INCOMN)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 1 trade in NEURIG DR PEPPER (INCOMN) (INCOMN) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ro Khanna sold $1,001 - $15,000 of NEURIG DR PEPPER (INCOMN) (INCOMN) on February 10, 2023. Since that trade, INCOMN is up +0.00% against the S&P 500 up +86.49%, an outperformance of -86.49%.
Data updated
Ro Khanna's INCOMN trades vs the price
INCOMN is up +0.00% since Ro Khanna sold on February 10, 2023, versus +86.49% for the S&P 500.
Performance since this trade
All Ro Khanna INCOMN trades
Ro Khanna & INCOMN trading FAQ
Is it legal for Ro Khanna to trade NEURIG DR PEPPER (INCOMN) (INCOMN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including NEURIG DR PEPPER (INCOMN) (INCOMN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna sell INCOMN?
Ro Khanna disclosed a sale of $1,001 - $15,000 of NEURIG DR PEPPER (INCOMN) (INCOMN) on February 10, 2023, according to public STOCK Act filings.
How has INCOMN performed since Ro Khanna's trade?
Since Ro Khanna sold INCOMN on February 10, 2023, the stock is up +0.00%, versus +86.49% for the S&P 500 over the same period, an outperformance of -86.49%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional INCOMN trades?
Quantellect tracks every disclosed congressional trade in NEURIG DR PEPPER (INCOMN) (INCOMN) on the NEURIG DR PEPPER (INCOMN) congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's INCOMN tradesAll congressional filings for NEURIG DR PEPPER (INCOMN)Ro Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.